Hansa Biopharma (Sweden) Price History

HNSA Stock  SEK 25.14  1.66  7.07%   
If you're considering investing in Hansa Stock, it is important to understand the factors that can impact its price. As of today, the current price of Hansa Biopharma stands at 25.14, as last reported on the 27th of February, with the highest price reaching 25.52 and the lowest price hitting 23.54 during the day. Hansa Biopharma AB holds Efficiency (Sharpe) Ratio of -0.0684, which attests that the entity had a -0.0684 % return per unit of risk over the last 3 months. Hansa Biopharma AB exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Hansa Biopharma's Market Risk Adjusted Performance of (0.17), risk adjusted performance of (0.02), and Standard Deviation of 4.58 to validate the risk estimate we provide.
  
Hansa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0684

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsHNSA

Estimated Market Risk

 4.79
  actual daily
42
58% of assets are more volatile

Expected Return

 -0.33
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Hansa Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hansa Biopharma by adding Hansa Biopharma to a well-diversified portfolio.

Hansa Biopharma Stock Price History Chart

There are several ways to analyze Hansa Stock price data. The simplest method is using a basic Hansa candlestick price chart, which shows Hansa Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 27, 202440.5
Lowest PriceFebruary 21, 202522.6

Hansa Biopharma February 27, 2025 Stock Price Synopsis

Various analyses of Hansa Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Hansa Stock. It can be used to describe the percentage change in the price of Hansa Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Hansa Stock.
Hansa Biopharma Accumulation Distribution 41,392 
Hansa Biopharma Price Rate Of Daily Change 1.07 
Hansa Biopharma Price Action Indicator 1.44 
Hansa Biopharma Price Daily Balance Of Power 0.84 

Hansa Biopharma February 27, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Hansa Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Hansa Biopharma intraday prices and daily technical indicators to check the level of noise trading in Hansa Stock and then apply it to test your longer-term investment strategies against Hansa.

Hansa Stock Price History Data

The price series of Hansa Biopharma for the period between Fri, Nov 29, 2024 and Thu, Feb 27, 2025 has a statistical range of 17.9 with a coefficient of variation of 14.98. Under current investment horizon, the daily prices are spread out with arithmetic mean of 30.91. The median price for the last 90 days is 31.54. The company completed 1015:964 stock split on 16th of March 2015.
OpenHighLowCloseVolume
02/26/2025 23.54  25.52  23.54  25.14  533,501 
02/25/2025 23.06  23.72  23.04  23.48  195,125 
02/24/2025 23.48  23.48  22.60  22.98  133,830 
02/21/2025 23.30  24.00  22.60  22.60  294,468 
02/20/2025 23.20  23.66  22.56  23.30  331,560 
02/19/2025 23.44  25.06  23.04  23.50  397,973 
02/18/2025 22.66  23.80  22.62  23.42  314,241 
02/17/2025 23.06  23.18  22.62  22.72  275,416 
02/14/2025 23.60  24.24  23.06  23.20  320,340 
02/13/2025 23.10  23.78  22.34  23.46  261,404 
02/12/2025 23.70  24.24  23.04  23.10  321,466 
02/11/2025 25.18  25.38  23.78  23.80  358,886 
02/10/2025 25.80  26.16  24.96  25.20  320,233 
02/07/2025 27.40  27.42  25.40  25.80  611,830 
02/06/2025 27.00  27.98  25.20  27.10  1,545,583 
02/05/2025 33.34  33.88  32.64  33.62  129,040 
02/04/2025 34.10  34.50  32.64  33.34  99,030 
02/03/2025 33.08  34.04  32.52  33.96  186,596 
01/31/2025 33.28  34.68  33.04  34.46  154,669 
01/30/2025 31.64  33.28  31.64  33.22  174,431 
01/29/2025 32.28  32.98  31.38  31.66  185,620 
01/28/2025 31.60  32.88  31.30  32.28  255,332 
01/27/2025 31.64  33.18  31.04  31.96  298,667 
01/24/2025 32.14  32.80  31.58  31.82  151,438 
01/23/2025 31.76  32.44  31.50  32.12  140,396 
01/22/2025 32.30  32.96  31.36  31.76  220,918 
01/21/2025 32.20  32.68  31.70  32.26  122,912 
01/20/2025 33.62  34.54  32.10  32.10  225,994 
01/17/2025 32.08  33.88  32.08  33.46  285,574 
01/16/2025 32.70  33.82  32.02  32.10  116,084 
01/15/2025 32.58  33.02  31.56  32.82  184,556 
01/14/2025 33.62  34.42  32.60  32.62  139,265 
01/13/2025 34.80  35.74  33.30  33.58  205,034 
01/10/2025 34.96  35.30  33.52  34.78  214,919 
01/09/2025 34.94  35.44  34.40  35.02  180,369 
01/08/2025 35.88  35.96  34.50  34.96  379,114 
01/07/2025 39.96  40.80  36.32  36.32  470,139 
01/03/2025 40.38  41.00  39.52  39.80  168,247 
01/02/2025 39.20  40.74  38.14  40.00  267,220 
12/30/2024 40.58  41.68  38.32  39.20  306,138 
12/27/2024 37.50  41.26  37.48  40.50  379,131 
12/23/2024 38.88  38.88  37.10  37.50  328,289 
12/20/2024 37.18  39.16  34.12  38.88  492,933 
12/19/2024 34.50  37.26  33.44  36.64  800,600 
12/18/2024 30.56  33.44  30.26  33.30  1,085,670 
12/17/2024 29.30  29.78  28.22  28.36  203,044 
12/16/2024 29.42  29.54  28.60  29.40  184,537 
12/13/2024 30.22  30.80  29.18  29.38  231,068 
12/12/2024 30.42  30.70  30.26  30.40  112,096 
12/11/2024 30.34  30.84  30.02  30.52  136,768 
12/10/2024 30.14  30.68  29.82  30.34  79,835 
12/09/2024 31.28  31.38  30.06  30.38  252,503 
12/06/2024 31.10  31.80  30.78  31.38  207,123 
12/05/2024 31.46  31.46  30.78  31.00  186,433 
12/04/2024 31.56  31.72  31.14  31.44  138,706 
12/03/2024 31.80  32.28  31.30  31.54  107,594 
12/02/2024 32.50  32.56  31.20  31.52  137,907 
11/29/2024 32.60  33.46  31.80  32.50  451,620 
11/28/2024 31.04  32.60  31.04  32.54  148,246 
11/27/2024 31.38  31.50  30.62  31.00  124,344 
11/26/2024 31.62  31.96  30.50  31.00  126,682 

About Hansa Biopharma Stock history

Hansa Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Hansa is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Hansa Biopharma AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Hansa Biopharma stock prices may prove useful in developing a viable investing in Hansa Biopharma
Hansa Biopharma AB , a biopharmaceutical company, focuses on developing novel immunomodulatory enzymes for organ transplantation and autoimmune diseases. Hansa Biopharma AB was founded in 2001 and is headquartered in Lund, Sweden. Hansa Biopharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 60 people.

Hansa Biopharma Stock Technical Analysis

Hansa Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Hansa Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Hansa Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module

Hansa Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Hansa Biopharma's price direction in advance. Along with the technical and fundamental analysis of Hansa Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Hansa to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Hansa Stock Analysis

When running Hansa Biopharma's price analysis, check to measure Hansa Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hansa Biopharma is operating at the current time. Most of Hansa Biopharma's value examination focuses on studying past and present price action to predict the probability of Hansa Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hansa Biopharma's price. Additionally, you may evaluate how the addition of Hansa Biopharma to your portfolios can decrease your overall portfolio volatility.